Global Custom Market Research Reports Provider Company

phone

Steris Plc (STE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 23 Oct 2018
  • Number of Pages: 38
  • Category: Company Profile
  • Country: United Kingdom
Summary

Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and barrier solutions. It also provides detergents and skin care products, laboratory testing, linen management and off-site reprocessing, microbial reduction of medical devices, and chemical and biological decontamination technologies for aircraft, buildings, vehicles, and sensitive equipment. Steris offers its products to medical device, healthcare, pharmaceutical, research and laboratory, and defense and industrial markets. The company markets and sells its products through direct sales force, distributors and dealers in the UK and abroad. Steris is headquartered in Derby, the UK.

Steris Plc (STE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Steris Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9
Steris Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Steris Plc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Synergy Health Completes Private Placement Of Shares For USD35 Million 11
Debt Offering 12
Steris Raises USD125 Million in Private Placement of 3.45% Notes Due 2025 12
Steris Raises USD100 Million in Priavte Placement of 3.75% Notes Due 2030 13
Steris Raises USD125 Million in Private Placement of 3.55% Notes Due 2027 14
Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2030 15
Steris Raises USD45 Million in Private Placement of 3.07% Notes Due 2023 16
Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2025 17
Steris Raises USD45.5 Million in Private Placement of 3.7% Notes Due 2022 18
Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2027 19
Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2024 20
Acquisition 21
Steris Acquires Synergy Health for USD2.3 Billion 21
Steris Acquires Biotest Labs 23
Steris Plc - Key Competitors 24
Steris Plc - Key Employees 25
Steris Plc - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 28
Recent Developments 29
Financial Announcements 29
Aug 08, 2018: STERIS Announces financial results for fiscal 2019 first quarter 29
Feb 07, 2018: STERIS Announces Financial Results for Fiscal 2018 Third Quarter 30
Nov 01, 2017: STERIS Announces Financial Results for Fiscal 2018 Second Quarter 31
Aug 08, 2017: STERIS Announces Financial Results for Fiscal 2018 First Quarter 32
May 09, 2017: STERIS Announces Financial Results for Fiscal 2017 Fourth Quarter and Full Year 33
Feb 07, 2017: STERIS Announces Financial Results for Fiscal 2017 Third Quarter 35
Corporate Communications 37
May 09, 2018: STERIS Announces Changes to Board of Directors 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List Of Tables


Steris Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Steris Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Steris Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9
Steris Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synergy Health Completes Private Placement Of Shares For USD35 Million 11
Steris Raises USD125 Million in Private Placement of 3.45% Notes Due 2025 12
Steris Raises USD100 Million in Priavte Placement of 3.75% Notes Due 2030 13
Steris Raises USD125 Million in Private Placement of 3.55% Notes Due 2027 14
Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2030 15
Steris Raises USD45 Million in Private Placement of 3.07% Notes Due 2023 16
Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2025 17
Steris Raises USD45.5 Million in Private Placement of 3.7% Notes Due 2022 18
Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2027 19
Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2024 20
Steris Acquires Synergy Health for USD2.3 Billion 21
Steris Acquires Biotest Labs 23
Steris Plc, Key Competitors 24
Steris Plc, Key Employees 25
Steris Plc, Subsidiaries 26
Steris Plc, Joint Venture 28

List Of Figures


Steris Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Steris Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

View Report

UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services

View Report

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports